According to new estimates from the joint United Nations Programme on human immunodeficiency virus (HIV) and the acquired immunodeficiency syndrome (AIDS) (UNAIDS) and the World Health Organization (WHO), about 33 million adults are living with HIV, and close to 70% of the total of HIV-positive people are from sub&ha-ran Africa. Diarrheal illnesses remain a major clinical problem for patients infected with HN; particularly those with the life-threatening AIDS. In Africa, diarrhea occurs in 60 to 90% of HIV infection' and "slim disease," prolonged diarrhea, and wasting usually, attributable to coccidian parasites, is pathognomic of AIDS in central Africa.',* Set-o prevalence of HIV in Senegal is about 1.6%, and nearly 80% of adults with AIDS present initially with diarrhea and weight loss. A wide variety of bacterial, viral, and parasitic pathogens can cause diarrhea in patients with advanced HIV infection. Although diarrhea occurs frequently, its optimal management remains controversial3 Bacterial pathogens in AIDS patients may manifest differently from infections in immunocompetent hosts. Other pathogens, including Cryptosporidium and Microsporidium, are difficult to diagnose and have no effective therapy. Moreover, enteric viruses and HIV itself may contribute to the diarrhea.* Only limited information is available regarding the etiology, clinical consequences, and immunologic effects of infection with diarrheal agents in the immunocompromised host. Consequently, the authors conducted a survey in Senegal among HIV-seropositive and HIV-seronegative subjects to identify major types and prevalences of bacteria, parasites, fungi, and Rotaviruses associated with diarrhea in adult patients, with the goal to provide guidance to physicians for case management.
MATERIALS AND METHODS

Study Population
Four groups of patients hospitalized in two Senegalese hospitals (Hopita Principal and Fann Teaching Hospital) were examined: group 1 comprised HIV-infected patients with diarrhea (HIV+ D+); group 2, HIV seronegative patients with diarrhea (HIV-D+); group 3, HIV-infected patients without diarrhea (HIV+ D->; group 4, HIV seronegative controls without diarrhea (HIV-D-). Control stool specimens (group 3 and group 4) were obtained from HIV-seropositive and HIV-seronegative adults selected from individuals who had no history of diarrheal illness during the preceding month. Cases (group 1 and group 2) were HIV-seropositive and HIV-seronegative hospitalized adults with diarrhea who had not received antibiotics during the previous 2 weeks, All subjects underwent complete physical examination and patient environment and history were recorded on a standardized questionnaire filled out by a physician. All aspects of the study were approved by the ad hoc Ethical Committee, and prior informed consent was obtained from included subjects.
HIV Serology and CD4 Counts
Human immunodeficiency virus serology was tested by two enzyme immunoassays (Genelavia Mixt, Sanofi Diagnostics Pasteur, Marries-la-Coquette, France, and Vironostika HIV Uni-Form II, Organon Teknika, Boxtel, The Netherlands), and confirmed by Western blotting (New Iav Blot, Sanofi Diagnostics Pasteur). CD4 lymphocyte counts were undertaken using a laser-based FACSCount system (Becton Dickinson Irnmunocytometry Systems, San Jose, CA, USA) for directly determining absolute CD4 count.
Microbiologic Analysis
All cases and controls had stool specimens collected and processed in the same way No transport media were used; specimens were quickly examined in the laboratory after collection. Freshly collected stool samples were examined immediately after collection, by dark-field microscopy, for motile bacteria, trophozoites, red blood cells, and leukocytes. Stool specimens were treated with saline and iodine preparations and examined for intestinal parasites; furthermore, formalin-ether concentrates and smears stained with Merthiolate-iodine-formaldehyde solution were prepared from each of the specimens and examined microscopically. Coccidia and Microsporidia were detected respectively by Kinyoun stain and modified trichrome stain with a high concentration of chromotrope 2 R. Table 1 . Phenotypic characterization of pathogenic E. coli was performed by a microtiter ganglioside enzyme linked immunosorbent assay (GMl-ELISA) for the thermolabile enterotoxin," the suckling mouse assay for the thermostable enterotoxin,'* and the guinea pig keratoconjunctivitis assay for enteroinvasive E. coli." All E. coli isolates were examined for HEp-2 cell adherence in eight-well chamber slides (LAB-TEK, Nunc Inc., Naperville, IL, USA), according to Vial et al.'* HEp-2 cell adherence was characterized as localized (IA), aggregate (AA), or diffuse (DA) adherence. HEp2 adherence pattern and virulence gene were performed on five colonies of E. coli. Escherichia coli was considered to be the etiologic agent of the diarrheal illness when a significant virulence gene was identified on at least three of five tested colonies. Serotypes of Salmonella spp and ShigeZZa spp were determined using slide agglutination.The antimicrobial susceptibility of bacterial enteropathogens was determined using the disk diffusion test.15 122-l 46 bfp = bundle-forming pilus; EPEC = enteropathogenic E. co/i; eaeA = E. co/i attaching and effacing gene A; LT = heat-labile anterotoxin; ETEC = anterotoxiganic E. co/i; STa = heat-stable enterotoxin; ipaH = invasion plasmid H; EIEC = enteroinvasive E. co/i; EAggEC = enteroaggregative E. co/i; SLT 1 = Shiga-Iike toxin 1; SLT 2 = Shiga-like toxin 2; DAEC = diffuse adherent E. co/i.
Statistic Analysis
Stastical analyses were performed using Epi Info, version 6.01 (Centers for Disease Control and Prevention, Atlanta, GA, USA) and SAS, version 6.12 (SAS Inc., Gary, NC, USA). For continuous variables normally distributed, means were compared using Student's t-test or the analysis of variance. Categoric variables were compared using the cm-squared test and Fisher's exact test where appropriate.
Potential risk factors of diarrhea among HIV-infected individuals were analyzed by univariate methods to determine possible inclusion in the multivariate model. All variables associated with diarrhea with a P-value of less than 0.3 were included in the multivariate analysis. Logistic regression analysis was performed to calculate odds ratio (OR) and 95% confidence interval (95% CD.
RESULTS
Among the 594 stool and blood samples analyzed, 279 were from cases and 315 were from controls.The characteristics of the studied population are described in Table 2 . The more frequent serotype, HIV-l, was identified in 90.9% (289/318) of the population; HIV-2 was identified in 5.3% (17/318), and 3.8% (12/318) of the study population were co-infected by both serotypes HIV-l and HIV-2. As expected, CD4 geometric mean cell counts were lower in HIV-infected than in HIVseronegative patients in cases as well as in controls (P < 0.000001). CD4 count was also significantly lower in diarrheic patients in HIV+ (P = 0.0007) as well as in HIV-(P < 0.0001) patients. There were no significant differences of age or gender among the four groups.
Identified bacterial pathogens are listed in Table 3 . No Yersinia spp, Vibrio spp, Plesiomonas spp, EHEC, Clostridium perfringens, or Mycobacterium spp were identified during this study Shigella spp and Salmonella spp were the most frequently identified bacterial pathogens during acute diarrhea; 28 Shigella were identified: Sbigella jlexneri (n = 14), Shigella dysenteriae (n = 12) and Shigella sonnei (n = 2); no Shigella boydii were identified. All Shigella strains were from cases except one S. sonnei isolated from a HIV-seronegative patient without diarrhea. No asymptomatic carriage of Shigella was observed in HIV-infected patients. Eighteen strains of Salmonella enterica (15 in cases; 3 in controls) were identified.
The various serotypes were S. enteritidis (5 among cases; 1 among controls), S. kentacky (2 among cases), S. typhi (1 among cases), S. sangera (1 among cases), S. magherafelt (1 among cases), S. tambacounda (2 among cases; 1 among controls), S. glostrup (1 among cases), and S. typhimurium (2 among cases and 1 among controls). Two CumpyZobacter jejuni infections were identified in HIV-D+ patients, and one Campylobacter fetus was identified in a seropositive patient with persistent diarrhea. Three strains of Aeromonas spp were identified in cases: two strains of A. hydropila in HIV-seronegative patients and one A. sob& (now referred to as A. veronii bv sob&) in an HIV seropositive patient. HEp-2 cell adherence patterns of E. coli strains showed three morphologic patterns: diffusely adherent E. coli was the most frequent pattern and was not differently isolated from cases and controls. The enteroaggregative HEp-2 adherence pattern was more often displayed by E. coli strains isolated from HIV-positive patients with diarrhea (Table 4) . Concerning the prevalence of different E. coli pathotypes identified by PCR (see Table 4 ), at least one target gene was found in 205 (34.5%) patients, and a target gene was found more often in cases (125/279,44.8%) than in controls @O/315,25.3%), P = 0.00001. Results show a high prevalence of afa gene in cases (66/219) as well as in controls (63/3 15); consequently pathogenic E. coli were E. coli strains with at least one virulence factor different from afu gene. Inversely, enteroaggregative and enteroinvasive E. coli seem to be closely related respectively to chronic and acute diarrhea. Isolation of enteroinvasive E. coli (ipaH gene ) was not dependent on HIV-serostatus, and no asymptomatic carriage was found for this pathotype. In contrast, enteroaggregative E. coli (EAgg gene) was isolated more frequently in HIV-seropositive patients (either alone or in association with other virulence genes: 34/318 in HIV-positive patients vs. 7/276 in HIVnegative patients). More than one virulence gene was more often observed in HIV-seropositive diarrheic patients (HrV+ D+ vs. HIV-D+: 21/158 vs. 3/121, P = 0.01; HIV+ D+ vs. HIV+ D-: 21/158 vs. 6/160, P = 0.2). Only one strain of E. coli carrying three virulence genes (afu, eae, EAgg) was identified in an HIV-seropositive patient with chronic diarrhea. Except for the ipaH gene, other virulence genes were identified in patients with CD4 count ranging from 11 to 259 cells/mm3. There was good correlation between genotypic and phenotypic characterization of enterotoxigenic and enteroinvasive E. coli. Two strains were positive in the GMl-ELBA test for heat-labile enterotoxin and in the suckling mouse model assay for heat-stable enterotoxin; all strains carrying @aH gene were positive for the guinea pig keratoconjunctivitis Sereny test. Unusual bacterial etiologies like Klebsiella pneumoniae (n = 7), Citrobacter freundii (n = 4) were found in immunocompromised patients with diarrhea. One of the Citrobacter spp strains was isolated from a 6&-year-old HIVseronegative woman with diabetes. The other strains were from HIV-seropositive patients with very low CD4 counts. In all these cases oral antibiotic therapy proved to be effective. These opportunistic bacterial pathogens were examined for HEp-2 cell adherence, and all showed a diffuse adherence pattern except three strains of K. pneumoniae, which displayed the "stacked-brick" aggregative adherence pattern typical of enteroaggregative E. coli strains and one strain of C. freundii (different from the one isolated from the 68-y-old woman) displaying the localized adherence attaching and effacing pattern typical of enteropathogenic E. coli. Polymerase chain reaction for E. coli virulence genes was negative for almost all strains except one K.pneumoniae with EAgg gene and one C. freundii gene with eae gene. Table 5 illustrates the antibiotic susceptibility of the 117 strains of bacterial enteropathogens recovered from cases and controls. All isolates were susceptible to am&a&, gentamicin, broadspectrum cephalosporin, and ciprofloxacin. Shigella spp and pathogenic E. coli were highly resistant to ampicillin, ticarcillin, cotrimoxazole, and tetracycline. Most enteropathogenic strains remained susceptible to ampicillin and clavulanic acid, third generation cephalosporins and fluoroquinolones. Interestingly, Salmonella strains remain susceptible to almost all antibiotics except tetracyclines.
Prevalence of different parasites, C. albicans, and Rotaviruses are shown in Table 6 . A high level of asymptomatic carriage of A. lumbricoides and Trichuris trichiura was observed. In the immunocompetent patients, the two main parasitic agents involved in diarrhea were Entamoeba histolytica and Giardia lamblia. The main opportunistic parasites are Microsporidium (9.4%), Cryptosporidium (8.2%), and Isospora belli dida ulbicans were observed in HIV-infected patients wth diarrhea. In almost all these cases patients were also undergoing oral candidiasis. Candida albicans was once isolated as the sole pathogen in an HIV-negative patient; in all cases fungi were isolated in patients with very low CD4 counts (range, 42-78 cells per mm'). Rotaviruses were identified in 13 HIV-infected patients and in two immunocompetent patients. Co-infection by two or more enteropathogenic agents was observed 11 times: Salmonella spp + Microsporidium (n = l), Cryptosporidium + A. lumbricoides (n = l), Salmonella + G. lamblia + T. trichiura (n = l), Microsporidium + E. coli + A. lumbricoides (n = 2), I. belli + 1: trichuria + A. lumbricoides (n = l), Cryptosporidium + C. albicans (n = 2), Shigella + A. lumbricoides (n = 2).
The risk of developing diarrhea increased progressively as CD4 counts fell below 200 cells/mm" ( Table 7) . The other independent risk factor was poor housing. Also patients younger than 40 years of age tended to be at higher risk.
DISCUSSION
Diarrhea is a prominent feature of AIDS in adults, and it causes significant morbidity in HIV-infected persons. This study confirms the association between persistent diarrhea and enteroaggregative E. coli previously suspected in other countries.'" However, some of the isolates from group 1 patients displayed the "stacked brick" aggregative adherence pattern on HEp-2 cells but lacked the typical virulence factor of enteroaggregative In the present study, about 30% of cases of diarrhea were of unknown etiology An extensive evaluation including stool studies and endoscopic biopsies of both colon and small intestine has been widely recommended to identify all potential pathogenic organisms." Stool viruses, such as adenovirus and coronavirus, were described as the possible causes of diarrhea in HIVinfected patients in Berlin. *l Unusual pathogens such as spirochetes have been described as a possible cause of diarrhea in HIV-infected persons in Central African Republic. l9 Moreover, enteric viruses and HIV itself may contribute to the diarrhea. In addition to microbes, other factors, such as medication, immune dysregulation, automatic dysfunction, and nutritional supplementation, play a substantial role in diarrhea in patients with AIDS.* The present findings suggest that coccidia should be considered to be etiologic agents for immunocompromised adults; the same results have been observed in other developing African countries.22 Conflicting evidence exists as to whether B. hominis should also be included among the infectious agents capable of causing HIV-related diarrhea. Albrecht et al found that association of B. hominis with clinical symptoms was not evident, and it is frequently associated with the concurrent isolation of other enteric pathogens. 23 In the present study, B. hominis has to be considered as an opportunistic parasite, because it was identified only in HIV-infected patients, with higher prevalence in adults with diarrhea, and in these cases it was not associated with other pathogens.
As found by other investigators,24 results of this study suggest that declining CD4 T-lymphocyte counts are associated with increased risk of diarrhea. Furthermore, the ftnding of lower CD4 counts among patients with diarrhea regardless to their HIV serostatus shows that diarrhea is a debilitating illness and suggests that effective management of diarrhea can prevent lmnmnosuppression. 
CONCLUSIONS
